受强制性开放获取政策约束的文章 - Carlos A Aya-Bonilla了解详情
可在其他位置公开访问的文章：9 篇
Isolation and detection of circulating tumour cells from metastatic melanoma patients using a slanted spiral microfluidic device
CA Aya-Bonilla, G Marsavela, JB Freeman, C Lomma, MH Frank, ...
Oncotarget 8 (40), 67355, 2017
强制性开放获取政策： US National Institutes of Health, National Health and Medical Research …
Detection and prognostic role of heterogeneous populations of melanoma circulating tumour cells
CA Aya-Bonilla, M Morici, X Hong, AC McEvoy, RJ Sullivan, J Freeman, ...
British journal of cancer 122 (7), 1059-1067, 2020
强制性开放获取政策： National Health and Medical Research Council, Australia
Melanoma circulating tumor cells: Benefits and challenges required for clinical application
G Marsavela, CA Aya-Bonilla, ME Warkiani, ES Gray, M Ziman
Cancer letters 424, 1-8, 2018
强制性开放获取政策： National Health and Medical Research Council, Australia
Preclinical efficacy of azacitidine and venetoclax for infant KMT2A-rearranged acute lymphoblastic leukemia reveals a new therapeutic strategy
LC Cheung, C Aya-Bonilla, MN Cruickshank, SK Chiu, V Kuek, ...
Leukemia 37 (1), 61-71, 2023
强制性开放获取政策： National Health and Medical Research Council, Australia, Swedish Research …
High‐resolution loss of heterozygosity screening implicates PTPRJ as a potential tumor suppressor gene that affects susceptibility to non‐hodgkin's lymphoma
C Aya‐Bonilla, MR Green, E Camilleri, M Benton, C Keane, P Marlton, ...
Genes, Chromosomes and Cancer 52 (5), 467-479, 2013
强制性开放获取政策： National Health and Medical Research Council, Australia
Immunomagnetic-enriched subpopulations of melanoma circulating tumour cells (CTCs) exhibit distinct transcriptome profiles
C Aya-Bonilla, ES Gray, J Manikandan, JB Freeman, P Zaenker, AL Reid, ...
Cancers 11 (2), 157, 2019
强制性开放获取政策： National Health and Medical Research Council, Australia
In silico analyses reveal common cellular pathways affected by loss of heterozygosity (LOH) events in the lymphomagenesis of Non-Hodgkin’s lymphoma (NHL)
C Aya-Bonilla, E Camilleri, LM Haupt, R Lea, MK Gandhi, LR Griffiths
BMC genomics 15, 1-12, 2014
强制性开放获取政策： National Health and Medical Research Council, Australia
Efficacy of DYRK1A inhibitors in novel models of Down syndrome acute lymphoblastic leukemia
SL Carey-Smith, MH Simad, K Panchal, C Aya-Bonilla, H Smolders, S Lin, ...
Haematologica 109 (7), 2309, 2024
强制性开放获取政策： National Health and Medical Research Council, Australia, European Commission …
Fine Mapping of the 15q21 Region Implicates TP53BP1 and B2M in the Lymphomagenesis of Follicular and Diffuse Large B-Cell Lymphomas
AB Carlos, C Emily, B Miles, MH Larisa, M Paula
J Carcinog Mutagen 5 (195), 2, 2014
强制性开放获取政策： National Health and Medical Research Council, Australia
出版信息和资助信息由计算机程序自动确定